Clincosm LogoSign in Get a demo

Effects of COVID-19 on the Elderly

Sponsor
Kırklareli University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05808348
Collaborator
(none)
120
Enrollment
1
Location
3.4
Anticipated Duration (Months)
34.8
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The goal of this observational study is to learn about in former COVID-19 patients. The main questions it aims to answer are:

  • are there any association among pain, fear of falling, fall frequency, and physical activity level

  • are there any difference between former COVID-19 elders and non-COVID-19 elderly population

Condition or Disease Intervention/Treatment Phase
  • Other: Scales and questionnaires

Study Design

Study Type:
Observational
Anticipated Enrollment :
120 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
Effect of COVID-19 On Pain, Fear of Falling, Fall Frequency, and Physical Activity Level in the Elderly
Actual Study Start Date :
Mar 2, 2023
Anticipated Primary Completion Date :
Jun 15, 2023
Anticipated Study Completion Date :
Jun 15, 2023

Arms and Interventions

Arm Intervention/Treatment
COVID-19 Group

Demographic and clinical information, Numerical Pain Rating Scale, Falls Efficacy Scale International, Baecke Physical Activity Questionnaire

Other: Scales and questionnaires
We will ask participants about their age, gender, height, weight, education level, medical history, number of falls in the last 1 year, status and length of COVID-19-related hospitalizations, and whether they have gotten the COVID-19 vaccine. The participants will be interviewed in person as part of the evaluation process. The Modified Baecke Physical Activity Questionnaire, the International Fall Activity Scale, and the Numerical Pain Scale will be used to assess the participants' levels of pain, fear of falling, and physical activity, respectively.
Healthy Group

Demographic and clinical information, Numerical Pain Rating Scale, Falls Efficacy Scale International, Baecke Physical Activity Questionnaire

Other: Scales and questionnaires
We will ask participants about their age, gender, height, weight, education level, medical history, number of falls in the last 1 year, status and length of COVID-19-related hospitalizations, and whether they have gotten the COVID-19 vaccine. The participants will be interviewed in person as part of the evaluation process. The Modified Baecke Physical Activity Questionnaire, the International Fall Activity Scale, and the Numerical Pain Scale will be used to assess the participants' levels of pain, fear of falling, and physical activity, respectively.

Outcome Measures

Primary Outcome Measures

  1. Fear of Falling [through study completion, an average of 6 months]

    Falls Efficacy Scale - International (total score between 16-64) (higher values indicate higher fear of falling)

Secondary Outcome Measures

  1. Pain Regions and Pain Severity [through study completion, an average of 6 months]

    Numerical Pain Rating Scale (total score between 0-10) (higher values indicate higher pain)

  2. Fall Frequency [through study completion, an average of 6 months]

    Fall Frequency in 1 year

  3. Physical Activity Level [through study completion, an average of 6 months]

    Baecke Physical Activity Questionnaire (total score between 3-15) (higher values indicate higher physical acitivity level)

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:

  • Being 65 years or older

  • Being cooperative

Exclusion Criteria:

  • Refusing to participate in the study

  • Having significant vision and hearing problems

  • Not completing the study questions

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kırklareli University Kırklareli Turkey 39000

Sponsors and Collaborators

  • Kırklareli University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ozan Gür, PT, Research Assistant, Kırklareli University
ClinicalTrials.gov Identifier:
NCT05808348
Other Study ID Numbers:
  • E-35523585-302.99-75492
First Posted:
Apr 11, 2023
Last Update Posted:
Apr 11, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:
COVID-19

Study Results

No Results Posted as of Apr 11, 2023